ALNYLAM PHARMACEUTICALS, INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | I | 90.10 | 2,615 | 235,612 | 0 | 2.6 K to 0 (-100.00 %) |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 3,500 | 55,965 | 154,248 | |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 10,000 | 71,000 | 20,000 | |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 81.45 | 400 | 32,579 | 3,905 | 4.3 K to 3.9 K (-9.29 %) |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 80.85 | 5,456 | 441,120 | 4,305 | 9.8 K to 4.3 K (-55.90 %) |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 80.02 | 11,465 | 917,469 | 9,761 | 21.2 K to 9.8 K (-54.01 %) |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 78.62 | 3,079 | 242,071 | 21,226 | 24.3 K to 21.2 K (-12.67 %) |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 3,500 | 55,965 | 24,305 | 20.8 K to 24.3 K (+16.82 %) |
| Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 10,000 | 71,000 | 20,805 | 10.8 K to 20.8 K (+92.55 %) |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 79.74 | 100 | 7,974 | 1,537 | 1.6 K to 1.5 K (-6.11 %) |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 79.04 | 2,110 | 166,769 | 1,637 | 3.7 K to 1.6 K (-56.31 %) |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 78.08 | 1,540 | 120,249 | 3,747 | 5.3 K to 3.7 K (-29.13 %) |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 6.78 | 19,500 | 132,210 | 44,300 | |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Payment of Exercise | F | 78.68 | 1,680 | 132,182 | 33,592 | 35.3 K to 33.6 K (-4.76 %) |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 6.78 | 19,500 | 132,210 | 35,272 | 15.8 K to 35.3 K (+123.64 %) |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 6.78 | 46,331 | 314,124 | 91,004 | |
| Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 6.78 | 46,331 | 314,124 | 77,613 | 31.3 K to 77.6 K (+148.11 %) |